Clinical Trials Browser

Phase 1 × Celecoxib × Head & Neck × Clear all

NCT00400374 2018-03-15

Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2

Phase 1 Completed

Head and Neck Neoplasms